NCT00019838 2015-04-29UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or LeukemiaNational Cancer Institute (NCI)Phase 1 Completed
NCT00058227 2013-06-04Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaNational Cancer Institute (NCI)Phase 1 Completed37 enrolled
NCT00806767 2011-05-17Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological CancerNational Cancer Institute (NCI)Phase 2 Completed82 enrolled